Using a computerized discharge summary data base check box for adverse drug reaction monitoring (Q33764366)

29 July 2017

Using a computerized discharge summary data base check box for adverse drug reaction monitoring (English)

1 reference

29 July 2017

G D Schiff

1

1 reference

29 July 2017

1 April 1990

1 reference

QRB. Quality review bulletin

29 July 2017

1 reference

29 July 2017

16

1 reference

29 July 2017

4

1 reference

29 July 2017

149-155

1 reference

Spontaneous reporting of adverse drug reactions. II: Uses

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Improving adverse drug reaction monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Adverse-drug-reaction monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Adverse drug event reporting. Improving the low US reporting rates

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Inherent limitations of the yellow card system for the detection of unsuspected adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Computer-assisted assessment of patient care in the hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

The ambiguity of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Assessing methods for causality assessment of suspected adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Reporting drug side effects: signals and noise

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

Drug Evaluation After Marketing

1 reference

https://api.crossref.org/works/10.1016%2FS0097-5990%2816%2930357-8

7 January 2021

10.1016/S0097-5990(16)30357-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

2113667